Discover the course
Artificial Intelligence in Pharmacovigilance and New Technologies. Do We Really Need them?
An overview of what the new digital technologies can do to improve cost/effectiveness and quality of Pharmacovigilance activities
This course covers:
- digital technologies from the regulatory framework to strategies, operational methods, and supporting technologies;
- how to exploit the wealth of up-to-date structured and unstructured pharmacovigilance related information available (from traditional and innovative sources);
- how to comply with current and future regulations;
- gives an overview of the available data in the pharmacovigilance domain and of how to turn it into useable information and valuable knowledge to improve effectiveness and quality.
Scope of the training is to enable participants to make informed decisions and plan/implement strategies on the use of artificial intelligence in pharmacovigilance to manage the available pharmacovigilance information.
- Current and possible future regulations
- Recent and future developments
- Volume vs. quality
- Case reports vs. intelligence
- Automated reporting
- What are the differences?
- Machine learning
- Artificial Intelligence
- Data science
Why do we need to do that?
- Examples from real life
Challenges and rewards
A possible approach: modular
A use case: social networks
A case analysis: pharmacovigilance and signal management
- Entry-level solutions
- Next-generation solutions
Building a simple case
The “human factor”
- How will employees react?
- What are the implications for training and career paths?
The course will be in English.
Marco Anelli has been appointed in January 2016 “Head of Pharmacovigilance and Medical Affairs Advisory Services” at PLG. As “Deputy Chief Scientific Officer” of PLG, Marco coordinates all delivery and research projects (internal and on behalf of clients) linked to Big Data, Knowledge Management, Artificial Intelligence and Machine Learning.
Previously, Marco was R&D Director at Keypharma, an Italy-based ProductLife Group company, where was responsible for the coordination of all clinical and preclinical aspects of projects run internally and on behalf of clients. Drawing on a career in the pharmaceutical industry that spans 25 years, Marco provides expert oversight on a wide range of R&D and Medical Affairs related activities. Marco has participated in and coordinated all stages of drug development – from formulation to Phase I-IV and pharmacovigilance. In addition, Marco is a qualified QPPV and has prepared and overseen more than 200 non-clinical and clinical overviews and summaries. Before joining Keypharma and PLG, Marco was Medical Affairs Director at Eurand. In the last few years, he has extensively worked in the fields of pharmacoeconomics and health technology assessment.
He has a medical degree from the University of Milan, specializations in Medical Statistics and Clinical Pharmacology from the University of Pavia and an international master’s degree in health economics and pharmacoeconomics from the University of Pompeu Fabra in Barcelona.
This one-and-a-half-day training course is designed to benefit functional/technical professionals coming from pharmaceutical and biotech companies, clinical research organizations (CROs) and public health centres dealing with the pharmacovigilance, such as:
- Qualified Person for Pharmacovigilance (QPPV)
- Pharmacovigilance officers
- Quality assurance
- Pharmacovigilance auditor
- Knowledge manager
- IT manager
Knowledge of basic pharmacovigilance
Basic knowledge of computers and productivity packages (Office, etc.)
Presentation, including hands-on exercises, and debates.
At your arrival you will find our Staff at the Welcome Desk to greet and make you feel welcome and as comfortable as possible, providing direction and all information about the meeting, seating, refreshments.
Coffee breaks and lunch will provide a pleasant moment of refreshment. Special care about the food quality, in particular to your dietary needs or preferences, from menus of local products and flavors to vegetarian dishes.
Limited number of participants to encourage networking and discussion.
All our training facilities are safe, healthy, comfortable, aesthetically-pleasing, and accessible. They are able to accommodate the specific space and equipment needs of the training program.
Depending on the seating configuration, the room may accommodate lecture-style instruction or encourage interaction in the form of roundtable discussions. Equipped for audio/visual, Free Wi-Fi to allow everyone to connect with just one click, electric sockets.
All the information necessary for learning during the course is provided. It is recommended to bring your PC to take notes (even directly on the slides provided in PDF format). The environment is important to us and that's why we try to make this meeting an experience of environmental sustainability.
Early Bird: € 1.280,00* (until 27 May 2020)
Ordinary: € 1.490,00*
Freelance - Academy - Public Administration**: € 780,00*
* for Italian companies: +22% VAT
**Early Bird discount not applicable to Freelance – Academy – Public Administration fee
The fee includes: tuitions, teaching materials, lunches and coffee breaks, organizational office assistance, attendance certificate.
Wednesday, May 27, 2020
At the end of the training, you will be able to
Have a working knowledge of relevant information on Artificial Intelligence in Pharmacovigilance
Have a working knowledge of the new technologies that could affect Pharmacovigilance operations in the near and medium-term future
Select the appropriate tools and processes to implement a new technologies-based approach
Set up simple but specific strategies
Interact with the tools and service vendors/providers to set up more complex solutions
Manage and report the information